Induction of PD-L1 Expression by the EML4-ALK Oncoprotein and Downstream Signaling Pathways in Non-Small Cell Lung Cancer
Ota, Keiichi, Azuma, Koichi, Kawahara, Akihiko, Hattori, Satoshi, Iwama, Eiji, Tanizaki, Junko, Harada, Taishi, Matsumoto, Koichiro, Takayama, Koichi, Takamori, Shinzo, Kage, Masayoshi, Hoshino, Tomoaki, Nakanishi, Yoichi, Okamoto, Isamu
Published in Clinical cancer research (01.09.2015)
Published in Clinical cancer research (01.09.2015)
Get full text
Journal Article
Response Heterogeneity of EGFR and HER2 Exon 20 Insertions to Covalent EGFR and HER2 Inhibitors
Kosaka, Takayuki, Tanizaki, Junko, Paranal, Raymond M, Endoh, Hideki, Lydon, Christine, Capelletti, Marzia, Repellin, Claire E, Choi, Jihyun, Ogino, Atsuko, Calles, Antonio, Ercan, Dalia, Redig, Amanda J, Bahcall, Magda, Oxnard, Geoffrey R, Eck, Michael J, Jänne, Pasi A
Published in Cancer research (Chicago, Ill.) (15.05.2017)
Published in Cancer research (Chicago, Ill.) (15.05.2017)
Get full text
Journal Article
Impact of EGFR-TKI Treatment on the Tumor Immune Microenvironment in EGFR Mutation-Positive Non-Small Cell Lung Cancer
Isomoto, Kohsuke, Haratani, Koji, Hayashi, Hidetoshi, Shimizu, Shigeki, Tomida, Shuta, Niwa, Takashi, Yokoyama, Toshihide, Fukuda, Yasushi, Chiba, Yasutaka, Kato, Ryoji, Tanizaki, Junko, Tanaka, Kaoru, Takeda, Masayuki, Ogura, Takashi, Ishida, Tadashi, Ito, Akihiko, Nakagawa, Kazuhiko
Published in Clinical cancer research (15.04.2020)
Published in Clinical cancer research (15.04.2020)
Get full text
Journal Article
Real‐world data on NGS using the Oncomine DxTT for detecting genetic alterations in non‐small‐cell lung cancer: WJOG13019L
Sakata, Shinya, Otsubo, Kohei, Yoshida, Hisako, Ito, Kentaro, Nakamura, Atsushi, Teraoka, Shunsuke, Matsumoto, Naohisa, Shiraishi, Yoshimasa, Haratani, Koji, Tamiya, Motohiro, Ikeda, Satoshi, Miura, Satoru, Tanizaki, Junko, Omori, Shota, Yoshioka, Hiroshige, Hata, Akito, Yamamoto, Nobuyuki, Nakagawa, Kazuhiko
Published in Cancer science (01.01.2022)
Published in Cancer science (01.01.2022)
Get full text
Journal Article
Mutational activation of the epidermal growth factor receptor down‐regulates major histocompatibility complex class I expression via the extracellular signal‐regulated kinase in non–small cell lung cancer
Watanabe, Satomi, Hayashi, Hidetoshi, Haratani, Koji, Shimizu, Shigeki, Tanizaki, Junko, Sakai, Kazuko, Kawakami, Hisato, Yonesaka, Kimio, Tsurutani, Junji, Togashi, Yosuke, Nishio, Kazuto, Ito, Akihiko, Nakagawa, Kazuhiko
Published in Cancer science (01.01.2019)
Published in Cancer science (01.01.2019)
Get full text
Journal Article
HER3 Augmentation via Blockade of EGFR/AKT Signaling Enhances Anticancer Activity of HER3-Targeting Patritumab Deruxtecan in EGFR-Mutated Non-Small Cell Lung Cancer
Yonesaka, Kimio, Tanizaki, Junko, Maenishi, Osamu, Haratani, Koji, Kawakami, Hisato, Tanaka, Kaoru, Hayashi, Hidetoshi, Sakai, Kazuko, Chiba, Yasutaka, Tsuya, Asuka, Goto, Hiroki, Otsuka, Eri, Okida, Hiroaki, Kobayashi, Maki, Yoshimoto, Ryoto, Funabashi, Masanori, Hashimoto, Yuuri, Hirotani, Kenji, Kagari, Takashi, Nishio, Kazuto, Nakagawa, Kazuhiko
Published in Clinical cancer research (15.01.2022)
Published in Clinical cancer research (15.01.2022)
Get full text
Journal Article
MET Tyrosine Kinase Inhibitor Crizotinib (PF-02341066) Shows Differential Antitumor Effects in Non-small Cell Lung Cancer According to MET Alterations
Tanizaki, Junko, Okamoto, Isamu, Okamoto, Kunio, Takezawa, Ken, Kuwata, Kiyoko, Yamaguchi, Haruka, Nakagawa, Kazuhiko
Published in Journal of thoracic oncology (01.10.2011)
Published in Journal of thoracic oncology (01.10.2011)
Get full text
Journal Article
Activation of HER Family Signaling as a Mechanism of Acquired Resistance to ALK Inhibitors in EML4-ALK―Positive Non―Small Cell Lung Cancer
TANIZAKI, Junko, OKAMOTO, Isamu, HATASHITA, Erina, NISHIO, Kazuto, NAKAGAWA, Kazuhiko, OKABE, Takafumi, SAKAI, Kazuko, TANAKA, Kaoru, HAYASHI, Hidetoshi, KANEDA, Hiroyasu, TAKEZAWA, Ken, KUWATA, Kiyoko, YAMAGUCHI, Haruka
Published in Clinical cancer research (15.11.2012)
Published in Clinical cancer research (15.11.2012)
Get full text
Journal Article
Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors
Tan, Li, Wang, Jun, Tanizaki, Junko, Huang, Zhifeng, Aref, Amir R, Rusan, Maria, Zhu, Su-Jie, Zhang, Yiyun, Ercan, Dalia, Liao, Rachel G, Capelletti, Marzia, Zhou, Wenjun, Hur, Wooyoung, Kim, NamDoo, Sim, Taebo, Gaudet, Suzanne, Barbie, David A, Yeh, Jing-Ruey Joanna, Yun, Cai-Hong, Hammerman, Peter S, Mohammadi, Moosa, Jänne, Pasi A, Gray, Nathanael S
Published in Proceedings of the National Academy of Sciences - PNAS (11.11.2014)
Published in Proceedings of the National Academy of Sciences - PNAS (11.11.2014)
Get full text
Journal Article
Targeting MET Amplification as a New Oncogenic Driver
Kawakami, Hisato, Okamoto, Isamu, Okamoto, Wataru, Tanizaki, Junko, Nakagawa, Kazuhiko, Nishio, Kazuto
Published in Cancers (22.07.2014)
Published in Cancers (22.07.2014)
Get full text
Journal Article
Book Review
FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib
Hibi, Masaaki, Kaneda, Hiroyasu, Tanizaki, Junko, Sakai, Kazuko, Togashi, Yosuke, Terashima, Masato, De Velasco, Marco Antonio, Fujita, Yoshihiko, Banno, Eri, Nakamura, Yu, Takeda, Masayuki, Ito, Akihiko, Mitsudomi, Tetsuya, Nakagawa, Kazuhiko, Okamoto, Isamu, Nishio, Kazuto
Published in Cancer science (01.11.2016)
Published in Cancer science (01.11.2016)
Get full text
Journal Article
CAPP-seq analysis of circulating tumor DNA from patients with EGFR T790M–positive lung cancer after osimertinib
Kato, Ryoji, Hayashi, Hidetoshi, Sakai, Kazuko, Suzuki, Shinichiro, Haratani, Koji, Takahama, Takayuki, Tanizaki, Junko, Nonagase, Yoshikane, Tanaka, Kaoru, Yoshida, Takeshi, Takeda, Masayuki, Yonesaka, Kimio, Kaneda, Hiroyasu, Nishio, Kazuto, Nakagawa, Kazuhiko
Published in International journal of clinical oncology (01.09.2021)
Published in International journal of clinical oncology (01.09.2021)
Get full text
Journal Article
Significance of micro-EGFR T790M mutations on EGFR-tyrosine kinase inhibitor efficacy in non-small cell lung cancer
Masuda, Takeshi, Miura, Satoru, Sato, Yuki, Tachihara, Motoko, Bessho, Akihiro, Nakamura, Atsushi, Miyawaki, Taichi, Yoshimine, Kohei, Mori, Masahide, Shiraishi, Hideaki, Hamai, Kosuke, Haratani, Koji, Maeda, Sumiko, Tabata, Eriko, Kitagawa, Chiyoe, Tanizaki, Junko, Imai, Takumi, Nogami, Shohei, Yamamoto, Nobuyuki, Nakagawa, Kazuhiko, Hattori, Noboru
Published in Scientific reports (13.11.2023)
Published in Scientific reports (13.11.2023)
Get full text
Journal Article
Targeting of the HER2/HER3 signaling axis overcomes ligand‐mediated resistance to trastuzumab in HER2‐positive breast cancer
Watanabe, Satomi, Yonesaka, Kimio, Tanizaki, Junko, Nonagase, Yoshikane, Takegawa, Naoki, Haratani, Koji, Kawakami, Hisato, Hayashi, Hidetoshi, Takeda, Masayuki, Tsurutani, Junji, Nakagawa, Kazuhiko
Published in Cancer medicine (Malden, MA) (01.03.2019)
Published in Cancer medicine (Malden, MA) (01.03.2019)
Get full text
Journal Article
Clinical characteristics of non-small cell lung cancer harboring mutations in exon 20 of EGFR or HER2
Takeda, Masayuki, Sakai, Kazuko, Hayashi, Hidetoshi, Tanaka, Kaoru, Tanizaki, Junko, Takahama, Takayuki, Haratani, Koji, Nishio, Kazuto, Nakagawa, Kazuhiko
Published in Oncotarget (20.04.2018)
Published in Oncotarget (20.04.2018)
Get full text
Journal Article
A Real-World Study on the Effectiveness and Safety of Pembrolizumab Plus Chemotherapy for Nonsquamous NSCLC
Fujimoto, Daichi, Miura, Satoru, Yoshimura, Kenichi, Wakuda, Kazushige, Oya, Yuko, Haratani, Koji, Itoh, Shoichi, Uemura, Takehiro, Morinaga, Ryotaro, Takahama, Takayuki, Nakashima, Kazuhisa, Tachihara, Motoko, Saito, Go, Tanizaki, Junko, Otsubo, Kohei, Ikeda, Satoshi, Matsumoto, Hirotaka, Hara, Satoshi, Hata, Akito, Masuda, Takeshi, Yamamoto, Nobuyuki
Published in JTO clinical and research reports (01.02.2022)
Published in JTO clinical and research reports (01.02.2022)
Get full text
Journal Article
T790M-Selective EGFR-TKI Combined with Dasatinib as an Optimal Strategy for Overcoming EGFR-TKI Resistance in T790M-Positive Non-Small Cell Lung Cancer
Watanabe, Satomi, Yoshida, Takeshi, Kawakami, Hisato, Takegawa, Naoki, Tanizaki, Junko, Hayashi, Hidetoshi, Takeda, Masayuki, Yonesaka, Kimio, Tsurutani, Junji, Nakagawa, Kazuhiko
Published in Molecular cancer therapeutics (01.11.2017)
Published in Molecular cancer therapeutics (01.11.2017)
Get full text
Journal Article
Clinical and immune profiling for cancer of unknown primary site
Haratani, Koji, Hayashi, Hidetoshi, Takahama, Takayuki, Nakamura, Yasushi, Tomida, Shuta, Yoshida, Takeshi, Chiba, Yasutaka, Sawada, Takahiro, Sakai, Kazuko, Fujita, Yoshihiko, Togashi, Yosuke, Tanizaki, Junko, Kawakami, Hisato, Ito, Akihiko, Nishio, Kazuto, Nakagawa, Kazuhiko
Published in Journal for immunotherapy of cancer (13.09.2019)
Published in Journal for immunotherapy of cancer (13.09.2019)
Get full text
Journal Article
Clinical implications of bronchoscopy for immune checkpoint inhibitor-related pneumonitis in patients with non-small cell lung cancer
Nishiyama, Osamu, Shimizu, Shigeki, Haratani, Koji, Isomoto, Kosuke, Tanizaki, Junko, Hayashi, Hidetoshi, Yamazaki, Ryo, Oomori, Takashi, Nishikawa, Yusaku, Sano, Akiko, Nakagawa, Kazuhiko, Tohda, Yuji
Published in BMC pulmonary medicine (08.05.2021)
Published in BMC pulmonary medicine (08.05.2021)
Get full text
Journal Article
Hemophagocytic lymphohistiocytosis induced by nivolumab/ipilimumab combination therapy: A case of lung adenocarcinoma that responded to early steroid pulse therapy
Hagiwara, Satoru, Tanizaki, Junko, Hayashi, Hidetoshi, Komeda, Yoriaki, Nishida, Naoshi, Yoshida, Akihiro, Yamamoto, Tomoki, Matsubara, Takuya, Kudo, Masatoshi
Published in Cancer reports (01.02.2024)
Published in Cancer reports (01.02.2024)
Get full text
Journal Article